TENAX THERAPEUTICS, INC. Derivative Liability
TENAX THERAPEUTICS, INC. (TENX) had Derivative Liability of $19.38 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2019-04-01
- 2018-09-30: Derivative Liability $19.38K.
- 2018-06-30: Derivative Liability $24.55K.
- 2018-03-31: Derivative Liability $20.70K.
- 2017-12-31: Derivative Liability $33.67K.
| Period end | Derivative Liability |
|---|---|
| 2018-09-30 | $19.38K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $24.55K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $20.70K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $33.67K 10-K · filed 2019-04-01 |
| 2017-09-30 | $36.08K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $72.16K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $55.32K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $226.09K 10-K · filed 2018-04-02 |
| 2016-09-30 | $310.27K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $370.40K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $293.44K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $524.34K 10-K · filed 2017-03-16 |
| 2015-10-31 | $502.69K 10-Q · filed 2015-12-10 |
| 2015-07-31 | $606.12K 10-Q · filed 2015-09-09 |
| 2015-04-30 | $572.45K 10-KT · filed 2016-03-14 |
| 2015-01-31 | $579.66K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $716.76K 10-Q · filed 2014-12-15 |
| 2014-07-31 | $680.68K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $954.88K 10-KT · filed 2016-03-14 |
| 2014-01-31 | $1.53M 10-Q · filed 2014-03-17 |
| 2013-04-30 | $0.00 10-K · filed 2014-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |